Difference and significance of peripheral blood T-lymphocyte subsets in patients with chronic hepatitis B and asymptomatic HBV carriers

National Medical Journal of China

Volumn 85, Issue 47, 2005, Pages 3354-3358

  Tian, Ying ^a   Qiu, Zhi Feng ^a   Li, Tai Sheng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Asymptomatic HBV carriers; Chronic; Hepatitis B; T lymphocyte subsets

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD8 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPATHOGENESIS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS CARRIER;

ADOLESCENT; ADULT; AGED; BLOOD DONORS; CARRIER STATE; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 32444441153     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Alatrakchi N, Koziel MJ. Antiviral T-cell responses and therapy in chronic hepatitis B. J Hepatol,2003,39:631-634.
2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat, 2004,11:97-107.
3. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis, 2002,2: 395-403.
4. Koziel MJ. The immunopathogenesis of HBV infection. Antivir Ther, 1998,3 (Suppl 3): 13-24.
5. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest, 1997,99: 1472-1477.
6. Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis, 2002,2: 43-50.
7. Fei GZ, Sylvan SP, Yao GB, et al. Quantitative monitoring of serum hepatitis B virus DNA and blood lymphocyte subsets during combined prednisolone and interferon-alpha therapy in patients with chronic hepatitis B. J Viral Hepat, 1999, 6:219-227.
8. Xu ZQ, Zhang HF, Yang XJ,et al. Association of T cell subsets with clinical status and hepatic pathology in children with chronic hepatitis B virus infection. Chinese J Clin Virol, 2004,18:142-144.
9. Liu XG, Fang GA, Jin XG,et al. The clinic significance of detecting T lymphocyte subsets and NK cell in the patients with chronic hepatitis B. Zhejiang J Clin Med, 2003,5:493-494.
10. Li YZ, Hu H, Wang M,et al. The changes of T-lymphocyte subsets and nature killer cell quantity in patients with hepatic diseases. J Dalian Med Univ, 2001,23:56-58.
11. Liu YX, Hu GL, He SY,et al. Effect of hepatitis virus infection of peripheral blood mononuclear cells on T cells subpopulation in patients with chronic hepatitis B. Chin J Modern Med, 2002,12:70-72.
12. Cai LJ, Xue R, Jiang CL. The changes of T-lymphocyte subsets in children with hepatitis B. J Southeast Univ (Med Sci Edi), 2003, 22:49-50.
13. Chinese Medical Association, Chinese Society of Infectious Diseases and Parasitology, Chinese Society of Liver Diseases. The prevention and treatment of viral hepatitis. Chin J Hepatol, 2000,8:324-329.
14. Tian ZG. Several problems in the research of NK cell. Chin J Immunol, 1999,15:142-144.
15. Choremi-Papadopoulou H, Panagiotou N, Samouilidou E, et al. CD28 costimulation and CD28 expression in T lymphocyte subsets in HIV-1 infection with and without progression to AIDS. Clin Exp Immunol, 2000,119:499-506.
16. Ostrowski SR, Gestoft J, Pedersen BK, et al. A low level of CD4 + CD28 + T cells is an independent predictor of high mortality in human immunodeficiency virus type 1-infected patients. J Infect Dis, 2003,187:1726-1734.
17. Zidovec Lepej S, Vince A, Dakovic Rode O, et al. Increased numbers of CD38 molecules on bright CD8 + T lymphocytes in infectious mononucleosis caused by Epstein-Barr virus infection. Clin Exp Immunol, 2003,133:384-390.
18. Belles-Isles M, Houde I, Lachance JG, et al. Monitoring of cytomegalovirus infections by the CD8 + CD38 + T-cell subset in kidney transplant recipients. Transplantation, 1998,65:279-282.
19. Bofill M, Borthwick NJ. CD38 in health and disease. Chem Immunol, 2000,75:218-234.
20. Lynne JE, Schmid I, Matud JL, et al. Major expansions of select CD8 + subsets in acute Epstein-Barr virus infection: comparison with chronic human immunodeficiency virus disease. J Infect Dis, 1998, 177:1083-1087.
21. Savarino A, Bottarel F, Malavasi F, et al. Role of CD38 in HIV-1 infection: an epiphenomenon of T-cell activation or an active player in virus/host interactions? AIDS, 2000,14:1079-1089.